FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Remifentanil Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 06/28/2022
»Therapeutic Categories: Analgesia/Addiction

Expand all

Fresenius Kabi USA, LLC (Reverified 11/05/2025)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)	Available	Check wholesalers for inventory
Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05)	Available	Check wholesalers for inventory
Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10)	Available	Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Revised 10/24/2025)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)	Available	Additional lots will be available. Product will be made available as it is released.
Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10)	Available	Additional lots will be available. Product will be made available as it is released.
Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)	Available	Additional lots will be available. Product will be made available as it is released.

Mylan Institutional, a Viatris Company (Revised 11/06/2025)

Company Contact Information:
800-796-9526

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ultiva, Injection, 2 mg (NDC 72078-035-02)	Available
Ultiva, Injection, 5 mg (NDC 72078-036-05)	Available
Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)	Available